虚血性脳卒中予防治療薬の世界市場（～2026年）

• 英文タイトル：Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12446
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は虚血性脳卒中予防治療薬のグローバル市場について調査・分析したレポートです。種類別（抗凝固療法、血行再建術、再灌流、抗血小板薬、神経保護薬）市場規模、用途別（病院、クリニック、緩和ケア、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別虚血性脳卒中予防治療薬の競争状況、市場シェア
・世界の虚血性脳卒中予防治療薬市場：種類別市場規模 2015年-2020年（抗凝固療法、血行再建術、再灌流、抗血小板薬、神経保護薬）
・世界の虚血性脳卒中予防治療薬市場：種類別市場規模予測 2021年-2026年（抗凝固療法、血行再建術、再灌流、抗血小板薬、神経保護薬）
・世界の虚血性脳卒中予防治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、緩和ケア、外来手術センター）
・世界の虚血性脳卒中予防治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、緩和ケア、外来手術センター）
・北米の虚血性脳卒中予防治療薬市場分析：米国、カナダ
・ヨーロッパの虚血性脳卒中予防治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの虚血性脳卒中予防治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の虚血性脳卒中予防治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの虚血性脳卒中予防治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Johnson & Johnson、Boston Therapeutics、Edge Therapeutics、Zocere、Lundbeck、ThromboGenics、Vernalis、Bayer、Bristol-Myers Squibb、Boehringer Ingelheim
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Ischemic Cerebral Stroke Prevention Therapeutics Market
The global Ischemic Cerebral Stroke Prevention Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Ischemic Cerebral Stroke Prevention Therapeutics Scope and Market Size
Ischemic Cerebral Stroke Prevention Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ischemic Cerebral Stroke Prevention Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Johnson & Johnson
Boston Therapeutics
Edge Therapeutics
Zocere
Lundbeck
ThromboGenics
Vernalis
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim

Market segment by Type, the product can be split into
Anticoagulation Therapy
Revascularization
Reperfusion
Antiplatelet
Neuroprotective
Market segment by Application, split into
Hospitals
Clinics
Palliative Care
Ambulatory Surgery Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ischemic Cerebral Stroke Prevention Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticoagulation Therapy
1.4.3 Revascularization
1.4.4 Reperfusion
1.4.5 Antiplatelet
1.4.6 Neuroprotective
1.5 Market by Application
1.5.1 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Palliative Care
1.5.5 Ambulatory Surgery Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Perspective (2015-2026)
2.2 Global Ischemic Cerebral Stroke Prevention Therapeutics Growth Trends by Regions
2.2.1 Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ischemic Cerebral Stroke Prevention Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Ischemic Cerebral Stroke Prevention Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ischemic Cerebral Stroke Prevention Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Ischemic Cerebral Stroke Prevention Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Ischemic Cerebral Stroke Prevention Therapeutics Players by Market Size
3.1.1 Global Top Ischemic Cerebral Stroke Prevention Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Ischemic Cerebral Stroke Prevention Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Concentration Ratio
3.2.1 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ischemic Cerebral Stroke Prevention Therapeutics Revenue in 2019
3.3 Ischemic Cerebral Stroke Prevention Therapeutics Key Players Head office and Area Served
3.4 Key Players Ischemic Cerebral Stroke Prevention Therapeutics Product Solution and Service
3.5 Date of Enter into Ischemic Cerebral Stroke Prevention Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ischemic Cerebral Stroke Prevention Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Ischemic Cerebral Stroke Prevention Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)
5.2 Global Ischemic Cerebral Stroke Prevention Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
6.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in North America (2019-2020)
6.3 North America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
6.4 North America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
7.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
7.4 Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
8.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in China (2019-2020)
8.3 China Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
8.4 China Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
9.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
9.4 Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
10.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
11.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in India (2019-2020)
11.3 India Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
11.4 India Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Size (2015-2020)
12.2 Ischemic Cerebral Stroke Prevention Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.1.4 Johnson & Johnson Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Boston Therapeutics
13.2.1 Boston Therapeutics Company Details
13.2.2 Boston Therapeutics Business Overview
13.2.3 Boston Therapeutics Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.2.4 Boston Therapeutics Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.2.5 Boston Therapeutics Recent Development
13.3 Edge Therapeutics
13.3.1 Edge Therapeutics Company Details
13.3.2 Edge Therapeutics Business Overview
13.3.3 Edge Therapeutics Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.3.4 Edge Therapeutics Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.3.5 Edge Therapeutics Recent Development
13.4 Zocere
13.4.1 Zocere Company Details
13.4.2 Zocere Business Overview
13.4.3 Zocere Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.4.4 Zocere Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.4.5 Zocere Recent Development
13.5 Lundbeck
13.5.1 Lundbeck Company Details
13.5.2 Lundbeck Business Overview
13.5.3 Lundbeck Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.5.4 Lundbeck Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.5.5 Lundbeck Recent Development
13.6 ThromboGenics
13.6.1 ThromboGenics Company Details
13.6.2 ThromboGenics Business Overview
13.6.3 ThromboGenics Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.6.4 ThromboGenics Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.6.5 ThromboGenics Recent Development
13.7 Vernalis
13.7.1 Vernalis Company Details
13.7.2 Vernalis Business Overview
13.7.3 Vernalis Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.7.4 Vernalis Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.7.5 Vernalis Recent Development
13.8 Bayer
13.8.1 Bayer Company Details
13.8.2 Bayer Business Overview
13.8.3 Bayer Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.8.4 Bayer Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.8.5 Bayer Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.9.4 Bristol-Myers Squibb Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Details
13.10.2 Boehringer Ingelheim Business Overview
13.10.3 Boehringer Ingelheim Ischemic Cerebral Stroke Prevention Therapeutics Introduction
13.10.4 Boehringer Ingelheim Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020)
13.10.5 Boehringer Ingelheim Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Ischemic Cerebral Stroke Prevention Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Ischemic Cerebral Stroke Prevention Therapeutics Revenue
Table 3. Ranking of Global Top Ischemic Cerebral Stroke Prevention Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticoagulation Therapy
Table 6. Key Players of Revascularization
Table 7. Key Players of Reperfusion
Table 8. Key Players of Antiplatelet
Table 9. Key Players of Neuroprotective
Table 10. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Ischemic Cerebral Stroke Prevention Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Ischemic Cerebral Stroke Prevention Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Ischemic Cerebral Stroke Prevention Therapeutics Players
Table 21. Global Ischemic Cerebral Stroke Prevention Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Ischemic Cerebral Stroke Prevention Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemic Cerebral Stroke Prevention Therapeutics as of 2019)
Table 24. Global Ischemic Cerebral Stroke Prevention Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Ischemic Cerebral Stroke Prevention Therapeutics Product Solution and Service
Table 27. Date of Enter into Ischemic Cerebral Stroke Prevention Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Ischemic Cerebral Stroke Prevention Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 37. North America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 39. North America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 43. Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 49. China Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 51. China Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 55. Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 67. India Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 69. India Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Ischemic Cerebral Stroke Prevention Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Ischemic Cerebral Stroke Prevention Therapeutics Market Share (2019-2020)
Table 73. Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application (2015-2020)
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 81. Johnson & Johnson Recent Development
Table 82. Boston Therapeutics Company Details
Table 83. Boston Therapeutics Business Overview
Table 84. Boston Therapeutics Product
Table 85. Boston Therapeutics Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 86. Boston Therapeutics Recent Development
Table 87. Edge Therapeutics Company Details
Table 88. Edge Therapeutics Business Overview
Table 89. Edge Therapeutics Product
Table 90. Edge Therapeutics Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 91. Edge Therapeutics Recent Development
Table 92. Zocere Company Details
Table 93. Zocere Business Overview
Table 94. Zocere Product
Table 95. Zocere Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 96. Zocere Recent Development
Table 97. Lundbeck Company Details
Table 98. Lundbeck Business Overview
Table 99. Lundbeck Product
Table 100. Lundbeck Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 101. Lundbeck Recent Development
Table 102. ThromboGenics Company Details
Table 103. ThromboGenics Business Overview
Table 104. ThromboGenics Product
Table 105. ThromboGenics Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 106. ThromboGenics Recent Development
Table 107. Vernalis Company Details
Table 108. Vernalis Business Overview
Table 109. Vernalis Product
Table 110. Vernalis Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 111. Vernalis Recent Development
Table 112. Bayer Business Overview
Table 113. Bayer Product
Table 114. Bayer Company Details
Table 115. Bayer Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 116. Bayer Recent Development
Table 117. Bristol-Myers Squibb Company Details
Table 118. Bristol-Myers Squibb Business Overview
Table 119. Bristol-Myers Squibb Product
Table 120. Bristol-Myers Squibb Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 121. Bristol-Myers Squibb Recent Development
Table 122. Boehringer Ingelheim Company Details
Table 123. Boehringer Ingelheim Business Overview
Table 124. Boehringer Ingelheim Product
Table 125. Boehringer Ingelheim Revenue in Ischemic Cerebral Stroke Prevention Therapeutics Business (2015-2020) (Million US$)
Table 126. Boehringer Ingelheim Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anticoagulation Therapy Features
Figure 3. Revascularization Features
Figure 4. Reperfusion Features
Figure 5. Antiplatelet Features
Figure 6. Neuroprotective Features
Figure 7. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Palliative Care Case Studies
Figure 11. Ambulatory Surgery Centers Case Studies
Figure 12. Ischemic Cerebral Stroke Prevention Therapeutics Report Years Considered
Figure 13. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Ischemic Cerebral Stroke Prevention Therapeutics Market Share by Players in 2019
Figure 18. Global Top Ischemic Cerebral Stroke Prevention Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemic Cerebral Stroke Prevention Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Ischemic Cerebral Stroke Prevention Therapeutics Revenue in 2019
Figure 20. North America Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Ischemic Cerebral Stroke Prevention Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

急性虚血性脳卒中治療薬の世界市場（～2026年）

Global Acute Ischemic Stroke Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13563 2020年11月30日 98Pages
当調査資料は急性虚血性脳卒中治療薬のグローバル市場について調査・分析したレポートです。種類別（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

虚血性脳卒中治療薬の世界市場（～2026年）

Global Ischemic Stroke Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY12447 2020年11月25日 99Pages
当調査資料は虚血性脳卒中治療薬のグローバル市場について調査・分析したレポートです。種類別（組織プラスミノーゲン活性化因子、抗凝固剤、抗血小板剤、降圧剤、その他）市場規模、用途別（病院、クリニック、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

心房細動（SPAF）治療における脳卒中予防の世界市場（～2026年）

Global Stroke Prevention in Atrial Fibrillation (SPAF) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04745 2020年11月20日 95Pages
当調査資料は心房細動（SPAF）治療における脳卒中予防のグローバル市場について調査・分析したレポートです。種類別（経口直接トロンビン阻害剤、経口直接因子Xa阻害剤）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

脳卒中診断・治療の世界市場（～2026年）

Global Stroke Diagnostics and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04743 2020年11月20日 97Pages
当調査資料は脳卒中診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（虚血性脳卒中、出血性脳卒中）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中...

脳マラリア治療薬の世界市場（～2026年）

Global Cerebral Malaria Therapeutics Market Insights and Forecast to 2026
MRC2-11QY00113 2020年11月20日 119Pages
当調査資料は脳マラリア治療薬のグローバル市場について調査・分析したレポートです。種類別（キニーネ、アルテミシニン誘導体）市場規模、用途別（小売薬局、オンライン薬局、病院薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

脳卒中管理の世界市場（～2026年）

Global Stroke Management Market Size, Status and Forecast 2020-2026
MRC2-11QY04744 2020年11月20日 97Pages
当調査資料は脳卒中管理のグローバル市場について調査・分析したレポートです。種類別（コンピュータ断層撮影スキャン（CTスキャン）、磁気共鳴画像法（MRI）、頸部超音波、脳血管造影、心電図、心エコー検査、その他）市場規模、用途別（虚血性脳卒中、出血性脳卒中）市場規模、地域別（北米、米国、カナダ、ヨーロッ...

脳脊髄液（CSF）管理の世界市場（～2026年）

Global Cerebral Spinal Fluid (CSF) Management Market Size, Status and Forecast 2020-2026
MRC2-11QY11327 2020年11月25日 94Pages
当調査資料は脳脊髄液（CSF）管理のグローバル市場について調査・分析したレポートです。種類別（CSFシャント、CSFドレナージ）市場規模、用途別（水頭症治療、その他脳関連障害治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

脳血管造影の世界市場（～2026年）

Global Cerebral Angiography Market Size, Status and Forecast 2020-2026
MRC2-11QY11326 2020年11月25日 91Pages
当調査資料は脳血管造影のグローバル市場について調査・分析したレポートです。種類別（磁気共鳴画像法、コンピューター断層撮影法、超音波、核画像法、X線）市場規模、用途別（病院、画像診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

院内肺炎予防の世界市場（～2026年）

Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2020-2026
MRC2-11QY12239 2020年11月25日 90Pages
当調査資料は院内肺炎予防のグローバル市場について調査・分析したレポートです。種類別（オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引ツール）市場規模、用途別（病院、リハビリテーションセンター、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

虚血性心疾患（IHD）薬の世界市場（～2026年）

Global Ischemic Heart Disease (IHD)Drugs Market Insights and Forecast to 2026
MRC2-11QY01832 2020年11月20日 110Pages
当調査資料は虚血性心疾患（IHD）薬のグローバル市場について調査・分析したレポートです。種類別（抗異脂肪血症薬、カルシウムチャネル遮断薬、ベータ遮断薬、ACE阻害薬、ARB、血管拡張薬、抗血栓薬）市場規模、用途別（安定狭心症、不安定狭心症、プリンツメタル狭心症、STEMI、NSTEMI）市場規模、地...

急性虚血性脳卒中治療薬の世界市場（～2026年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
心房細動（SPAF）治療における脳卒中予防の世界市場（～2026年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…
脳卒中診断・治療の世界市場（～2026年） Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced. Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed …
脳マラリア治療薬の世界市場（～2026年） During cerebral malaria there is a state of unarousable coma with malaria infected blood in the peripheral circulation. The condition of coma is due to some other type of infections or hypoglycemia. The presence of retinopathy has been an addition in the clinical diagnosis of both adult and children…